The appointment of Pazdur as CDER head comes shortly after the surprise ousting of George Tidmarsh and should quiet many of the “lingering uncertainties” surrounding the FDA, wrote one industry analyst.
Richard Pazdur, longtime FDA oncology leader, to head agency’s main drug office